Developer docs
API playgroundTry for free, no card

Search company profiles

Sarphati Amsterdam

Full company profile

uuid003j923

Namestring
Sarphati Amsterdam
Legal namestring
Sarphati Amsterdam
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Sarphati Amsterdam is a publicly funded scientific research initiative founded in March 2018 as a partnership between the City of Amsterdam (via GGD Amsterdam), Amsterdam UMC (locations AMC and VUmc), Vrije Universiteit Amsterdam, the University of Amsterdam, the Hogeschool van Amsterdam, and SAG Zorgontwikkeling. Its mission is to conduct long-term, multidisciplinary research on the healthy growth and development of Amsterdam children aged 0–18 and to translate findings into practical tools for policymakers and healthcare practitioners that reduce child health disparities.

The core asset is the Sarphati Cohort, a dynamic longitudinal research database that combines routine Youth Health Services (JGZ) consultation data — covering growth, sleep, nutrition, physical activity, sedentary behaviour, parental psychosocial burden, environment, and demographics — with age-specific parental surveys. Data is pseudonymised and the cohort continuously recruits new participants, enabling cross-sectional, longitudinal, cohort-effect, and intervention research. The infrastructure supports dynamic addition of variables, sub-cohorts (such as the Amsterdam Infant Microbiome Study, AIMS, launched in 2019), and randomised interventions with built-in control groups. Through JGZ, the cohort covers approximately 98% of all Amsterdam children. A multilingual Sarphati App (Dutch, English, Spanish, French, German, Turkish, Moroccan-Arabic) handles informed consent and participant communication.

Sarphati Amsterdam is not a commercial enterprise. It is financed through municipal and institutional contributions, with core partners accessing existing cohort data without charge and external researchers covering data-provision costs on a negotiated basis. Research results are disseminated to the Municipality of Amsterdam for policy use, to practice professionals through periodic Sarphati Explore events and an annual Symposium, and to academic audiences via publications, LinkedIn, the Open Research Amsterdam platform, and the GGD Amsterdam website. As of 2024, more than 11,000 families were participating in the cohort.

Short descriptiontext

Sarphati Amsterdam is a publicly funded research consortium that operates the Sarphati Cohort, a dynamic longitudinal study tracking the growth and development of Amsterdam children aged 0–18, and translates findings into policy and practice tools for municipal and healthcare partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAmsterdam, Netherlands
HQ citystring
Amsterdam
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
child health research, longitudinal cohort study, public health data, microbiome research, urban health monitoring
Industry3 codes
PRIMARYHLAJANAN
Sentinel Site & Community-Based Surveillance
SECONDARYHLAJAOAG
Maternal, Newborn, Child & Adolescent Health (MNCAH) Partnerships
SECONDARYEDADADAJ
Early Childhood & Child Development Policy Research
Education/Education Administration, Accreditation & Policy/Education Policy, Research & Think Tanks
NAICS code2 codes
  • Child and Youth Services62411
  • Individual and Family Services6241
SIC code2 codes
  • Services-Health Services8000
  • Services-Social Services8300
Product category
Public Health Research
Social media profiles1 record
Revenue model2 records
1Institutional / governmental funding
TypeLicensing Royalties
Description

Sarphati Amsterdam is a partnership between the City of Amsterdam (via GGD Amsterdam), Amsterdam UMC, VU Amsterdam, UvA, and HvA. The initiative appears to be publicly funded through municipal and institutional contributions. Core partners (municipality, universities, hospital) access existing Sarphati Cohort data without financial contribution; external organisations cover data provision costs.

sarphati.amsterdam
2Research collaboration fees
TypeProfessional Services
Description

External organisations (non-partner) requesting Sarphati Cohort data must cover data provision costs. Sub-cohort initiation costs (additional staffing for recruitment, inclusion, and data management) are borne by the requesting researcher/organisation. Fees are negotiated on a case-by-case basis.

sarphati.amsterdam
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Sarphati Amsterdam is a scientific research initiative that operates the Sarphati Cohort, a dynamic longitudinal study tracking Amsterdam children aged 0-18, collecting routine Youth Health Care (JGZ) data combined with parental questionnaires. It runs the AIMS sub-study on infant microbiome development and offers researchers structured access to anonymised cohort data, sub-cohort initiation, and randomised intervention capabilities. Research findings are translated into practical tools for municipal policymakers and youth healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • More than 11,000 participating families contributing data on child health (as of 2024)
+3 more records
Product overview1 text field

Sarphati Amsterdam is a research initiative comprising a primary longitudinal cohort study (Sarphati Cohort) tracking Amsterdam children from 0-18 years, a microbiome sub-study (AIMS), a multilingual consent application, and regular professional events (Sarphati Explore and Annual Symposium). These components work together to collect, analyze, and disseminate knowledge about children's health and development in urban environments.

Product and service5 records
1Sarphati Cohort
CategoryResearch Program
Description

Large-scale longitudinal research program tracking Amsterdam children aged 0-18, collecting data on growth, nutrition, sleep, exercise, mental health, and other health outcomes, with pseudonymised data made available to approved researchers.

2AIMS (Amsterdam Infant Microbiome Study)
CategorySub-study
Description

Sub-study investigating the development of microorganisms in and on young children's bodies and how the microbiome influences diabetes, obesity, cardiovascular diseases, and oral health problems.

3Sarphati App
CategoryDigital Application
Description

Mobile and web application providing multilingual (Dutch, English, Spanish, French, German, Turkish, Moroccan-Arabic) study information, an animated explainer video, and parental informed-consent flows for the Sarphati Cohort.

4Sarphati Explore
CategoryEvent Series
Description

Recurring thematic professional gatherings that bring together researchers, policymakers, and practitioners to discuss specific child health themes such as sleep, nutrition, motor skills, and oral health.

5Sarphati Symposium
CategoryAnnual Event
Description

Annual large symposium featuring multiple themes around healthy child development in Amsterdam, with plenary presentations and interactive parallel sessions.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1Jump-in programme (GGD Amsterdam school nutrition intervention)
Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Jump-in is a school-based dietary intervention programme evaluated through the Sarphati Cohort. Research showed implementation on schools leads to healthier food consumption and positive influence on children's BMI.

sarphati.amsterdam
Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

A collaboration network between Amsterdam UMC (Public and Occupational Health department) and eight JGZ organisations across North Holland and Flevoland (including GGD Amsterdam, GGD Hollands Noorden, GGD Zaanstreek-Waterland, GGD Kennemerland, GGD Flevoland, and JGZ Almere), plus regional municipalities. Sarphati Amsterdam participates in AWJG activities.

3EndObesity consortium (ZonMw funded)
Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

A research consortium focused on developing, implementing, and evaluating innovative strategies for preventing childhood obesity, including a prediction model within JGZ. Collaborates with the Sarphati Cohort for data and implementation.

sarphati.amsterdam
Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

An informal community organisation conducting poverty consultation sessions in Amsterdam neighbourhoods. Partnered with researchers on the 'Gezonde en Kansrijke Start' programme to interview young mothers in their own languages, improving research access to underrepresented groups.

Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

A dietetics practice with multiple locations across Amsterdam neighbourhoods, providing practical insights on nutrition counselling for families. Contributes practice expertise to Sarphati Explore events and research-practice collaboration.

6Baby Groente Tas (Baby Vegetable Bag project)
Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

An intervention project providing free vegetable bags with preparation tools to parents of babies starting solid food (4–6 months) to promote healthy eating habits. Presented as an example of research-policy-practice collaboration within Sarphati Amsterdam.

sarphati.amsterdam
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

GGD Amsterdam is the core institutional partner, providing the Youth Health Services (JGZ) infrastructure through which the Sarphati Cohort collects data from all participating children during routine health consultations. GGD's JGZ and SAG Zorgontwikkeling manage and provide growth and development data.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Amsterdam University Medical Center (both Academic Medical Center and VUmc locations) provides academic research expertise, hosts researchers, and contributes to the governance and scientific direction of Sarphati Amsterdam.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

VU Amsterdam is a founding knowledge institution partner, contributing research leadership (notably Prof. Jaap Seidell, founding director). VU researchers actively use Sarphati Cohort data for public health research on nutrition, obesity, and child development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

UvA is a founding knowledge institution partner contributing research expertise across disciplines including sociology, child development, and public health. UvA researchers (e.g., Christian Bröer) conduct ethnographic studies within the Sarphati framework.

11Hogeschool van Amsterdam (HvA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

HvA (Amsterdam University of Applied Sciences) is a founding knowledge institution partner contributing applied research expertise and student involvement to the Sarphati Amsterdam initiative.

sarphati.amsterdam
12SAG Zorgontwikkeling (Stichting Amsterdamse Gezondheidscentra) — Jeugdgezondheidszorg
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

The Amsterdam Health Foundation (SAG) — Child Health Services section (JGZ) — is a core partner providing the second pathway for child health data collection alongside GGD Amsterdam's JGZ. SAG's Ouder- en Kindteams (OKT) deliver health consultations to Amsterdam children.

sarphati.amsterdam
13City of Amsterdam (municipality)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

The municipality of Amsterdam is the governing authority behind the initiative, with an alderman on the Governing Board responsible for Health and Social Development and Public Health and Prevention portfolios. The municipality provides funding and strategic direction.

sarphati.amsterdam
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Association of Dutch regional public health services, including GGD Amsterdam; comparable in municipal-public-health remit but at a national scale.

TypeDirect peer
Description

Large-scale Danish birth cohort following ~100,000 children; structurally analogous in scale, longitudinal design, and routine-registry data linkage.

TypeBroad incumbent
Description

Dutch national public-health authority that historically housed Seidell and operates population-health surveillance; broader mandate and not a direct competitor but a relevant institutional incumbent.

4Generation R Study
TypeDirect peer
Description

Large population-based birth cohort in Rotterdam tracking children from fetal life onward; structurally analogous to the Sarphati Cohort in scale, longitudinal design, and Dutch academic-municipal governance model.

5Norwegian Mother, Father and Child Cohort Study (MoBa)
TypeDirect peer
Description

Norwegian population-based pregnancy and child cohort operated by the Norwegian Institute of Public Health; comparable in design and child-health focus.

TypeDirect peer
Description

UK urban birth cohort with high ethnic diversity and routine-NHS-linked data infrastructure; directly comparable in mission to track child health in a multi-ethnic urban setting.

TypeDirect peer
Description

Large multi-generational Dutch population cohort based in the north of the Netherlands; comparable longitudinal design, though broader in scope (all ages) rather than child-specific.

8ALSPAC (Avon Longitudinal Study of Parents and Children)
TypeDirect peer
Description

Long-running UK birth cohort following children and parents with deep phenotyping; comparable longitudinal scope and influence on public health research.

TypeDirect peer
Description

Amsterdam-based birth cohort following children from pregnancy through adolescence; operates in the same city and overlapping academic ecosystem, making it the most direct local comparator.

10Generation Victoria (GenV)
TypeEmerging player
Description

Australia-wide whole-of-state birth and parent cohort; emerging large-scale comparator with similar ambitions for embedded interventions and policy translation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sarphati Amsterdam

Public Health Researchsarphati.amsterdam

Sarphati Amsterdam is a publicly funded research consortium that operates the Sarphati Cohort, a dynamic longitudinal study tracking the growth and development of Amsterdam children aged 0–18, and translates findings into policy and practice tools for municipal and healthcare partners.

What Sarphati Amsterdam does

Sarphati Amsterdam is a publicly funded scientific research initiative founded in March 2018 as a partnership between the City of Amsterdam (via GGD Amsterdam), Amsterdam UMC (locations AMC and VUmc), Vrije Universiteit Amsterdam, the University of Amsterdam, the Hogeschool van Amsterdam, and SAG Zorgontwikkeling. Its mission is to conduct long-term, multidisciplinary research on the healthy growth and development of Amsterdam children aged 0–18 and to translate findings into practical tools for policymakers and healthcare practitioners that reduce child health disparities.

The core asset is the Sarphati Cohort, a dynamic longitudinal research database that combines routine Youth Health Services (JGZ) consultation data — covering growth, sleep, nutrition, physical activity, sedentary behaviour, parental psychosocial burden, environment, and demographics — with age-specific parental surveys. Data is pseudonymised and the cohort continuously recruits new participants, enabling cross-sectional, longitudinal, cohort-effect, and intervention research. The infrastructure supports dynamic addition of variables, sub-cohorts (such as the Amsterdam Infant Microbiome Study, AIMS, launched in 2019), and randomised interventions with built-in control groups. Through JGZ, the cohort covers approximately 98% of all Amsterdam children. A multilingual Sarphati App (Dutch, English, Spanish, French, German, Turkish, Moroccan-Arabic) handles informed consent and participant communication.

Sarphati Amsterdam is not a commercial enterprise. It is financed through municipal and institutional contributions, with core partners accessing existing cohort data without charge and external researchers covering data-provision costs on a negotiated basis. Research results are disseminated to the Municipality of Amsterdam for policy use, to practice professionals through periodic Sarphati Explore events and an annual Symposium, and to academic audiences via publications, LinkedIn, the Open Research Amsterdam platform, and the GGD Amsterdam website. As of 2024, more than 11,000 families were participating in the cohort.

Sarphati Amsterdam firmographics

Firmographics
Name
Sarphati Amsterdam
Legal name
Sarphati Amsterdam
Website
https://sarphati.amsterdam
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Sarphati Amsterdam is a publicly funded research consortium that operates the Sarphati Cohort, a dynamic longitudinal study tracking the growth and development of Amsterdam children aged 0–18, and translates findings into policy and practice tools for municipal and healthcare partners.
Ownership category
akta.pro rank

Sarphati Amsterdam industry classification

Industry
Product category
Public Health Research
NAICS
Child and Youth Services (62411), Individual and Family Services (6241)
SIC
Services-Health Services (8000), Services-Social Services (8300)
akta.pro industry
PRIMARYHLAJANAN
Sentinel Site & Community-Based Surveillance
SECONDARYHLAJAOAG
Maternal, Newborn, Child & Adolescent Health (MNCAH) Partnerships
SECONDARYEDADADAJ
Early Childhood & Child Development Policy Research
Education/Education Administration, Accreditation & Policy/Education Policy, Research & Think Tanks

Keywords

  • Child health research
  • Longitudinal cohort study
  • Public health data
  • Microbiome research
  • Urban health monitoring

Where Sarphati Amsterdam is headquartered

Location

Headquarters

HQ city
Amsterdam
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Sarphati Amsterdam business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Institutional / governmental funding: Sarphati Amsterdam is a partnership between the City of Amsterdam (via GGD Amsterdam), Amsterdam UMC, VU Amsterdam, UvA, and HvA. The initiative appears to be publicly funded through municipal and institutional contributions. Core partners (municipality, universities, hospital) access existing Sarphati Cohort data without financial contribution; external organisations cover data provision costs.
  2. Research collaboration fees: External organisations (non-partner) requesting Sarphati Cohort data must cover data provision costs. Sub-cohort initiation costs (additional staffing for recruitment, inclusion, and data management) are borne by the requesting researcher/organisation. Fees are negotiated on a case-by-case basis.

Distribution channels3 records

Marketing channels8 records

Sarphati Amsterdam product offering

Product offering

Core offering

Sarphati Amsterdam is a scientific research initiative that operates the Sarphati Cohort, a dynamic longitudinal study tracking Amsterdam children aged 0-18, collecting routine Youth Health Care (JGZ) data combined with parental questionnaires. It runs the AIMS sub-study on infant microbiome development and offers researchers structured access to anonymised cohort data, sub-cohort initiation, and randomised intervention capabilities. Research findings are translated into practical tools for municipal policymakers and youth healthcare professionals.

Product overview

Sarphati Amsterdam is a research initiative comprising a primary longitudinal cohort study (Sarphati Cohort) tracking Amsterdam children from 0-18 years, a microbiome sub-study (AIMS), a multilingual consent application, and regular professional events (Sarphati Explore and Annual Symposium). These components work together to collect, analyze, and disseminate knowledge about children's health and development in urban environments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sarphati Cohort Large-scale longitudinal research program tracking Amsterdam children aged 0-18, collecting data on growth, nutrition, sleep, exercise, mental health, and other health outcomes, with pseudonymised data made available to approved researchers.
  • AIMS (Amsterdam Infant Microbiome Study) Sub-study investigating the development of microorganisms in and on young children's bodies and how the microbiome influences diabetes, obesity, cardiovascular diseases, and oral health problems.
  • Sarphati App Mobile and web application providing multilingual (Dutch, English, Spanish, French, German, Turkish, Moroccan-Arabic) study information, an animated explainer video, and parental informed-consent flows for the Sarphati Cohort.
  • Sarphati Explore Recurring thematic professional gatherings that bring together researchers, policymakers, and practitioners to discuss specific child health themes such as sleep, nutrition, motor skills, and oral health.
  • Sarphati Symposium Annual large symposium featuring multiple themes around healthy child development in Amsterdam, with plenary presentations and interactive parallel sessions.

Quantifiable outcome

  • More than 11,000 participating families contributing data on child health (as of 2024)
  • +3 more outcomes

Companies that use Sarphati Amsterdam

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Sarphati Amsterdam technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Sarphati Amsterdam partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered supporting and core.

  • Jump-in programme (GGD Amsterdam school nutrition intervention)supportingStrategic or Co-development Partner · 1 January 2024Jump-in is a school-based dietary intervention programme evaluated through the Sarphati Cohort. Research showed implementation on schools leads to healthier food consumption and positive influence on children's BMI.
  • Academische Werkplaats Jeugd en Gezondheid (AWJG) — Academic Workplaces Youth and Health networksupportingStrategic or Co-development Partner · 1 January 2023A collaboration network between Amsterdam UMC (Public and Occupational Health department) and eight JGZ organisations across North Holland and Flevoland (including GGD Amsterdam, GGD Hollands Noorden, GGD Zaanstreek-Waterland, GGD Kennemerland, GGD Flevoland, and JGZ Almere), plus regional municipalities. Sarphati Amsterdam participates in AWJG activities.
  • EndObesity consortium (ZonMw funded)supportingStrategic or Co-development Partner · 1 January 2023A research consortium focused on developing, implementing, and evaluating innovative strategies for preventing childhood obesity, including a prediction model within JGZ. Collaborates with the Sarphati Cohort for data and implementation.
  • SomastelsupportingStrategic or Co-development Partner · 1 January 2023An informal community organisation conducting poverty consultation sessions in Amsterdam neighbourhoods. Partnered with researchers on the 'Gezonde en Kansrijke Start' programme to interview young mothers in their own languages, improving research access to underrepresented groups.
  • FitFood DiëtistenpraktijksupportingStrategic or Co-development Partner · 1 January 2023A dietetics practice with multiple locations across Amsterdam neighbourhoods, providing practical insights on nutrition counselling for families. Contributes practice expertise to Sarphati Explore events and research-practice collaboration.
  • Baby Groente Tas (Baby Vegetable Bag project)supportingStrategic or Co-development Partner · 1 January 2023An intervention project providing free vegetable bags with preparation tools to parents of babies starting solid food (4–6 months) to promote healthy eating habits. Presented as an example of research-policy-practice collaboration within Sarphati Amsterdam.
  • GGD Amsterdam (Public Health Service of Amsterdam)coreStrategic or Co-development Partner · 1 January 2018GGD Amsterdam is the core institutional partner, providing the Youth Health Services (JGZ) infrastructure through which the Sarphati Cohort collects data from all participating children during routine health consultations. GGD's JGZ and SAG Zorgontwikkeling manage and provide growth and development data.
  • Amsterdam UMC (locations AMC and VUmc)coreStrategic or Co-development Partner · 1 January 2018Amsterdam University Medical Center (both Academic Medical Center and VUmc locations) provides academic research expertise, hosts researchers, and contributes to the governance and scientific direction of Sarphati Amsterdam.
  • Vrije Universiteit (VU) AmsterdamcoreStrategic or Co-development Partner · 1 January 2018VU Amsterdam is a founding knowledge institution partner, contributing research leadership (notably Prof. Jaap Seidell, founding director). VU researchers actively use Sarphati Cohort data for public health research on nutrition, obesity, and child development.
  • Universiteit van Amsterdam (UvA)coreStrategic or Co-development Partner · 1 January 2018UvA is a founding knowledge institution partner contributing research expertise across disciplines including sociology, child development, and public health. UvA researchers (e.g., Christian Bröer) conduct ethnographic studies within the Sarphati framework.
  • Hogeschool van Amsterdam (HvA)coreStrategic or Co-development Partner · 1 January 2018HvA (Amsterdam University of Applied Sciences) is a founding knowledge institution partner contributing applied research expertise and student involvement to the Sarphati Amsterdam initiative.
  • SAG Zorgontwikkeling (Stichting Amsterdamse Gezondheidscentra) — JeugdgezondheidszorgcoreStrategic or Co-development Partner · 1 January 2018The Amsterdam Health Foundation (SAG) — Child Health Services section (JGZ) — is a core partner providing the second pathway for child health data collection alongside GGD Amsterdam's JGZ. SAG's Ouder- en Kindteams (OKT) deliver health consultations to Amsterdam children.
  • City of Amsterdam (municipality)coreStrategic or Co-development Partner · 1 January 2018The municipality of Amsterdam is the governing authority behind the initiative, with an alderman on the Governing Board responsible for Health and Social Development and Public Health and Prevention portfolios. The municipality provides funding and strategic direction.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Sarphati Amsterdam competitors and assessment

Company assessment

Broad incumbents

  • GGD GHOR Nederland: Association of Dutch regional public health services, including GGD Amsterdam; comparable in municipal-public-health remit but at a national scale.
  • RIVM (National Institute for Public Health and the Environment): Dutch national public-health authority that historically housed Seidell and operates population-health surveillance; broader mandate and not a direct competitor but a relevant institutional incumbent.

Direct peers

  • Danish National Birth Cohort: Large-scale Danish birth cohort following ~100,000 children; structurally analogous in scale, longitudinal design, and routine-registry data linkage.
  • Generation R Study: Large population-based birth cohort in Rotterdam tracking children from fetal life onward; structurally analogous to the Sarphati Cohort in scale, longitudinal design, and Dutch academic-municipal governance model.
  • Norwegian Mother, Father and Child Cohort Study (MoBa): Norwegian population-based pregnancy and child cohort operated by the Norwegian Institute of Public Health; comparable in design and child-health focus.
  • Born in Bradford: UK urban birth cohort with high ethnic diversity and routine-NHS-linked data infrastructure; directly comparable in mission to track child health in a multi-ethnic urban setting.
  • Lifelines: Large multi-generational Dutch population cohort based in the north of the Netherlands; comparable longitudinal design, though broader in scope (all ages) rather than child-specific.
  • ALSPAC (Avon Longitudinal Study of Parents and Children): Long-running UK birth cohort following children and parents with deep phenotyping; comparable longitudinal scope and influence on public health research.
  • ABCD Study (Amsterdam Born Children and their Development): Amsterdam-based birth cohort following children from pregnancy through adolescence; operates in the same city and overlapping academic ecosystem, making it the most direct local comparator.

Emerging players

  • Generation Victoria (GenV): Australia-wide whole-of-state birth and parent cohort; emerging large-scale comparator with similar ambitions for embedded interventions and policy translation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sarphati Amsterdam social profiles

Digital presence

Sarphati Amsterdam financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sarphati Amsterdam leadership team

Management profile

Number of profiles

Profiles1 record

Sarphati Amsterdam funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sarphati Amsterdam M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sarphati Amsterdam

What does Sarphati Amsterdam do?

Sarphati Amsterdam is a scientific research initiative that operates the Sarphati Cohort, a dynamic longitudinal study tracking Amsterdam children aged 0-18, collecting routine Youth Health Care (JGZ) data combined with parental questionnaires. It runs the AIMS sub-study on infant microbiome development and offers researchers structured access to anonymised cohort data, sub-cohort initiation, and randomised intervention capabilities. Research findings are translated into practical tools for municipal policymakers and youth healthcare professionals.

Is Sarphati Amsterdam a public or private company?

Sarphati Amsterdam is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Sarphati Amsterdam founded?

Sarphati Amsterdam was founded in 2018. It employs 1 to 10 people.

Where is Sarphati Amsterdam based?

Sarphati Amsterdam is headquartered in Amsterdam, Netherlands, in the Europe region.

How does Sarphati Amsterdam make money?

Two revenue lines are on record. Institutional / governmental funding is the primary driver. The others are research collaboration fees.

Who are Sarphati Amsterdam's main competitors?

Broad incumbents on record are GGD GHOR Nederland and RIVM (National Institute for Public Health and the Environment). Direct peers are Danish National Birth Cohort, Generation R Study, Norwegian Mother, Father and Child Cohort Study (MoBa), Born in Bradford, Lifelines, ALSPAC (Avon Longitudinal Study of Parents and Children) and ABCD Study (Amsterdam Born Children and their Development). Generation Victoria (GenV) is listed as an emerging player.

Does Sarphati Amsterdam have an API?

No public API is recorded for Sarphati Amsterdam.

What industry is Sarphati Amsterdam in?

Sarphati Amsterdam's product category is Public Health Research. Its primary akta.pro industry code is HLAJANAN, Sentinel Site & Community-Based Surveillance, with a secondary code of HLAJAOAG, Maternal, Newborn, Child & Adolescent Health (MNCAH) Partnerships. Its NAICS code is 62411 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales